<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
Washington, D.C. 20549 </b></font></p>
<p align="center"><b><font face="serif" size="4">FORM 8-K </font></b></p>
<p align="center"><font size="2" face="serif">________________</font></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT</b></font></p>
<p align="center"><font size="2" face="serif"><b>PURSUANT TO SECTION 13 OR 15(d)<br>OF THE SECURITIES EXCHANGE ACT OF 1934 </b></font></p>
<p align="center"><font size="2" face="serif"><b>December 18, 2006<br>
Date of Report (Date of Earliest Event Reported)</b></font></p>
<p align="center"><font size="2" face="serif"><b>________________________</b></font></p>
<p align="center"><font size="4" face="serif"><b>POLYMEDIX, INC.<br>
      <font size="2">(Exact name of registrant as specified in its charter) </font></b></font></p>
<p align="center"><font size="2" face="serif">_____________________</font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
<td align="center" valign="top"><font size="2" face="serif"><b>Delaware</b></font></td>
<td width="30%" align="center" valign="top"><font size="2" face="serif"><b>000-51895</b></font></td>
<td width="30%" align="center" valign="top"><font size="2" face="serif"><b>27-0125925</b></font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(State or other jurisdiction<br>of incorporation)</font></b></font></td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Commission File Number)</font></b></font></td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(IRS Employer</font></b></font><br><font size="2" face="serif"><b><font face="serif" size="1">Identification No.)</font></b></font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="center" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="center" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="center" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b>170 N. Radnor-Chester Road; <br>
  Suite 300</b></font><br><font size="2" face="serif"><b>Radnor, PA</b></font></td>
<td align="center" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="center" valign="bottom"><font size="2" face="serif"><b>19087<br>
  </b></font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Address of principal executive offices)</font></b></font></td>
<td align="center" valign="top"><font size="2" face="serif">&nbsp;</font></td>
<td align="center" valign="top"><font size="2" face="serif"><b><font face="serif" size="1">(Zip
    Code)</font></b></font></td>
<td align="left">&nbsp;</td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>484-598-2332<br>
      <font size="1">(Registrant&#8217;s telephone number, including area code)</font></b></font></p>
<p align="center"><font size="2" face="serif"><b>PolyMedix, Inc.<br>
3701 Market Street; Suite 442<br>
Philadelphia, PA 19104<br>
<font size="1">(Former name or address, if changed since last report)</font></b></font></p>
<p align="center"><font size="2" face="serif">____________________</font></p>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="4%"><img src="emptybox.gif" width="12" height="12"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<p>&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page> <a name="p?"></a><br>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="16%"><font size="2" face="serif"><b>Item 8.01.</b></font></td>
<td align="left"><font size="2" face="serif"><b>Other Events</b></font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">On December 18, 2006, the Board of Directors of PolyMedix, Inc. (the &#8220;Company&#8221;) declared a dividend to be payable on December 31, 2006 to the holders of record as of that date of the Company&#8217;s issued and outstanding shares of its Series 1 Convertible Preferred Stock (the &#8220;Series 1 Stock&#8221;), as provided in the Company&#8217;s Certificate of Designations.  The dividend is payable in shares of Series 1 Stock, accrued at an annual rate of 6%, or $0.18 per share.</font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
</table>
<p align="center">&nbsp;</p>
<p align="center">&nbsp;</p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p align="center"><font size="2" face="serif"><b>SIGNATURE</b></font></p>
<p align="left"><font size="2" face="serif">Pursuant to the requirements of the
    Securities Exchange Act of 1934, the registrant has duly caused this report
    to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="left">&nbsp;</p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="50%">&nbsp;</td>
    <td><font size="2" face="serif">POLYMEDIX, INC.</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">/s/ Edward F. Smith</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><hr size="1" noshade></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Edward F. Smith</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><font size="2" face="serif">Vice President, Finance and Chief Financial
    Officer</font></td>
  </tr>
</table>
<p align="left"><font size="2" face="serif"></font></p>
<p align="left"><font size="2" face="serif">December 20, 2006</font></p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b416575_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 7945}]
{"company-data": {"conformed-name": "POLYMEDIX INC", "cik": "0001341843", "assigned-sic": "2834", "irs-number": "000000000"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51895", "film-number": "061289124"}, "business-address": {"street1": "C/O POLYMEDIX INC", "street2": "3701 MARKET STREET STE 442", "city": "PHILADELPHIA", "state": "PA", "zip": "19104", "phone": "2159666199"}, "mail-address": {"street1": "C/O POLYMEDIX INC", "street2": "3701 MARKET STREET STE 442", "city": "PHILADELPHIA", "state": "PA", "zip": "19104"}, "former-company": {"former-conformed-name": "BTHC II ACQUISITION CORP", "date-changed": "20051019"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
December 18, 2006
Date of Report (Date of Earliest Event Reported)
________________________
POLYMEDIX, INC.
(Exact name of registrant as specified in its charter)
_____________________
Delaware
000-51895
27-0125925
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
170 N. Radnor-Chester Road;
Suite 300
Radnor, PA
19087
(Address of principal executive offices)
(Zip
    Code)
484-598-2332
(Registrant's telephone number, including area code)
PolyMedix, Inc.
3701 Market Street; Suite 442
Philadelphia, PA 19104
(Former name or address, if changed since last report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01.
Other Events
On December 18, 2006, the Board of Directors of PolyMedix, Inc. (the "Company") declared a dividend to be payable on December 31, 2006 to the holders of record as of that date of the Company's issued and outstanding shares of its Series 1 Convertible Preferred Stock (the "Series 1 Stock"), as provided in the Company's Certificate of Designations.  The dividend is payable in shares of Series 1 Stock, accrued at an annual rate of 6%, or $0.18 per share.
SIGNATURE
Pursuant to the requirements of the
    Securities Exchange Act of 1934, the registrant has duly caused this report
    to be signed on its behalf by the undersigned hereunto duly authorized.
POLYMEDIX, INC.
/s/ Edward F. Smith
Edward F. Smith
Vice President, Finance and Chief Financial
    Officer
December 20, 2006